Stay updated on REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Results for NCT03515629 have been posted, including updates to primary and secondary outcomes and the overall study status. The primary endpoint PFS is noted as not assessed due to insufficient data, with other outcomes outlined.
    Difference
    0.4%
    Check dated 2025-11-03T21:21:32.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    4%
    Check dated 2025-10-06T05:56:43.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:54.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' element was removed as a minor UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-14T20:01:18.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T17:00:24.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding St. Petersburg, Florida, and the drug names cemiplimab and pembrolizumab, while removing previous location and drug references.
    Difference
    4%
    Check dated 2025-08-31T12:13:07.000Z thumbnail image

Stay in the know with updates to REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REGN2810 Combo vs Pembrolizumab in Lung Cancer Clinical Trial page.